易层贴敷疗法对兔膝骨性关节炎滑膜基质金属蛋白酶的影响

茆军; 张立; 赵凌睿; 丁亮; 王培民

易层贴敷疗法对兔膝骨性关节炎滑膜基质金属蛋白酶的影响

茆军^1,2,
张立¹,
赵凌睿¹,
丁亮²,
王培民^2,3,

1.
南京中医药大学第一临床医学院，江苏南京 210023
2.
南京中医药大学附属医院，江苏南京 210029
3.
全国名中医诸方受传承工作室，江苏南京 210029

计量
- 文章访问数: 797
- HTML全文浏览量: 3
- PDF下载量: 976
- 被引次数: 0
出版历程
- 收稿日期: 2013-09-19
- 修回日期: 2014-01-05
- 刊出日期: 2014-03-10

The Effect of Layers Adjusting External Application Therapy on Matrix Metalloproteinases in Synovial Membrane in the Rabbit Knee Osteoarthritis

MAOJun^1,2,
ZHANGLi¹,
ZHAOLin-rui¹,
DINGLiang²,
WANGPei-min^{2,3
,}

1.
The First Medical College of Nanjing University of Chinese Medicine, Nanjing, 210023, China
2.
Affiliated Hospital of Nanjing University of TCM, Nanjing, 210029, China
3.
The Inheritance Studio of Famous Aged Chinese Doctor Zhu Fang-shou, Nanjing, 210029, China

摘要

摘要: 目的研究易层贴敷疗法对骨性关节炎（OA）中滑膜炎症因子及基质金属蛋白酶表达的影响。方法 30只新西兰大白兔，随机分为正常组、模型对照组及治疗组；模型对照组及治疗组通过切断兔左后肢前交叉韧带获得OA模型，术后6周外用易层贴敷；术后8周处死动物，取滑膜行Western Blot及荧光定量PCR检测IL-1β、MMP-1及MMP-13的含量及表达。结果 Western Blot测定模型对照组滑膜中MMP-1及MMP-13含量明显高于治疗组，正常组中含量最低；荧光定量PCR测定模型对照组中MMP-1及MMP-13的表达量最高，正常组最低；正常组滑膜中IL-1β表达明显最低，模型对照组与治疗组之间无统计学差异。结论易层贴敷疗法能有效抑制滑膜中MMP-1及MMP-13的表达，从而降低了软骨基质的降解，缓解OA的进程，仍需进一步研究其具体的作用靶点，完善其作用机制。
- 易层贴敷疗法 /
- 骨性关节炎 /
- 滑膜 /
- 基质金属蛋白酶
Abstract: OBJECTIVE To investigate the effect of Layers Adjusting External Application Therapy on the expression of synovial inflammatory factors and matrix metalloproteinase (MMPs) in osteoarthritis (OA). METHODS 30 New Zealand rabbits were randomly divided into normal group， control group and treatment group. OA model was induced in rabbit by unilateral posterior anterior cruciate ligament transection (ACLT). 6 weeks post-operation， the Layers Adjusting External Application Therapy were used externally; 8 weeks post-operation， the rabbits were sacrificed. The synovial membrane specimens were taken to detect the expression and content of IL-1β， MMP-1 and MMP-13 by Western Blot and Fluorogenic Quantitative PCR. RESULTS Western Blot: The content of MMP-1 and MMP-13 in the control group were significantly higher than the treatment group. The content of MMP-1 and MMP-1 in the normal group were the lowest Fluorogenic Quantitative PCR. The expression of MMP-1 and MMP-13 in the control group were the highest the expression of MMP-1 and MMP-13 in the normal group were the lowest the expression of IL-1β in the normal group was significantly lowest. There were no significantly differences in the expression of IL-1β between control group and treatment group. CONCLUSION Layers Adjusting External Application Therapy can effectively inhibit the expression of MMP-1 and MMP-13 in the Synovial Membrane， thus reduces the degradation of cartilage matrix alleviate the progression of OA. Nevertheless， further research are needed to investigate the specific target so that the mechanism of the therapy can be revealed.
- layers adjusting external application therapy /
- osteoarthritis /
- synovial membrane /
- matrix metalioproteinases

HTML全文

参考文献(12)

[1]	Scanzello CR， Goldring SR. The role of synovitis in osteoarthritis pathogenesis[J]. Bone， 2012， 52(2): 249-257.
[2]	Bondeson J， Wainwright SD， Lauder S， et al. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases， matrix metalloproteinases， and other destructive and inflammatory responses in osteoarthritis[J]. Arthritis Res Ther， 2006， 8(6):187.
[3]	Huskisson EC， Berry H， Gishen P， et al. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis[J]. J Rheumatol， 1995， 22(10):1941-1946.
[4]	尹恒，马勇，王建伟. “易层”贴敷疗法治疗膝骨性关节炎60例临床研究[J]. 国医论坛， 2011， 26(5):17-18.
[5]	Yin H， Ma Y， Wang JW. 60 cases clinical research on "Yiceng" paste treating on Knee Osteoarthritis[J]. Forum on Tradit Chin Med， 2011，26(5):17-18.
[6]	Vignon E， Arlot M， Hartmann D， et al. Hypertrophic repair of articular cartilage in experimental osteoarthrosis[J]. Ann Rheum Dis， 1983， 42(1):82-88.
[7]	Bao JP， Chen WP， Feng J， et al. Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: Regulation by dehydroepiandrosterone[J]. Clin Chem Acta， 2009， 408(1-2):1-7.
[8]	Chen WP， Yu C， Hu PF， et al. Stigmasterol blocks cartilage degradation in rabbit model of osteoarthritis[J]. Acta Biochim Pol， 2012， 59(4):537-541.
[9]	Duclos ME， Roualdes O， Cararo R， et al. Significance of the serum CTX-II level in an osteoarthritis animal model: a 5-month longitudinal study[J]. Osteoarthritis Cartilage， 2010， 18(11):1467-1476.
[10]	Domagala F， Martin G， Bogdanowicz P， et al. Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis[J]. Biorheology， 2006， 43(3-4):577-587.
[11]	Luyten FP， Tylzanowski P， Lories RJ. Wnt signaling and osteoarthritis[J]. Bone， 2009， 44(4):522-527.
[12]	Ma B， van Blitterswijk CA， Karperien M. A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes[J]. Arthritis Rheum， 2012， 64(8):2589-2600.